Have a personal or library account? Click to login
Understanding genetic information as a commons:  From bioprospecting to personalized medicine Cover

Understanding genetic information as a commons: From bioprospecting to personalized medicine

By: Nicola Lucchi  
Open Access
|Aug 2013

References

  1. Adair 1997 Adair J. R The Bioprospecting Question: Should the United States Charge Biotechnology Companies for the Commercial Use of Public Wild Genetic Resources Ecology Law Quarterly 1997 24 131 171
  2. Albright 2004 Albright M Profits Pending: How Life Patents Represent the Biggest Swindle of the 21st Century 2004 Monroe Common Courage Press
  3. American Civil Liberties Union 2009 American Civil Liberties Union Legal Challenge to Human Gene Patents. Available at: http://www.aclu.org/pdfs/freespeech/brca_qanda.pdf. 2009
  4. Andonian 1989 Andonian J Environment Changing in Pharmaceuticals Les Nouvelles 1989 24 48
  5. Andrews and Paradise 2005 Andrews L. B Paradise J Gene Patents: The Need for Bioethics Scrutiny and Legal Change Yale Journal of Health Policy Law, and Ethics 2005 5 403 412
  6. Aseff 2011 Aseff A First Federal Prohibition on Bioprospecting within a Place of Protection: Time to Spur the Legislative Dialogue Colorado Journal of International Environmental Law and Policy 2011 22 189 218
  7. Australian Law Reform Commission 2004 Australian Law Reform Commission Genes and Ingenuity: Gene Patenting and Human Health, Report 99 2004 Sydney Australian Commonwealth Available at: http://www.austlii.edu.au/au/other/alrc/publications/reports/99/
  8. Benkler 2000a Benkler Y Constitutional Bounds of Database Protection: The Role of Judicial Review in the Creation and Definition of Private Rights in Information Berkeley Technology Law Journal 2000a 15 535 603
  9. Benkler 2000b Benkler Y An Unhurried View of Private Ordering in Information Transactions Vanderbilt Law Review 2000b 55 2063 2080
  10. Bently and Sherman 2009 Bently L Sherman B Intellectual Property Law 2009 3rd ed Oxford Oxford University Press
  11. Bessen and Meurer 2008 Bessen J Meurer M. J Patent Failure: How Judges, Bureaucrats, and Lawyers Put Innovators at Risk 2008 Princeton Princeton University Press
  12. Boettiger and Burk 2004 Boettiger S Burk D. L Open Source Patenting Journal of International Biotechnology Law 2004 1 221 231
  13. Boldrin and Levine 2008 Boldrin M Levine D. K Against Intellectual Monopoly 2008 Cambridge Cambridge University Press
  14. Bowman 1996 Bowman M Bowman M Redgwell C The Nature, Development and Philosophical Foundations of the Biodiversity Concept in International law International Law And Conservation Of Biological Diversity 1996 The Hauge Kluwer Law International 5 31
  15. Boyle 1996 Boyle J Shamans, Software & Spleens 1996 Cambridge Harvard University Press
  16. Boyle 2003 Boyle J The Second Enclosure Movement and the Construction of the Public Domain Law & Contemporary Problems 2003 66 33 74
  17. Burk and Lemley 2009 Burk D. L Lemley M. A The Patent Crisis and How the Courts Can Solve It 2009 Chicago, IL University of Chicago Press
  18. Chambers 2002 Chambers J. C Patent Eligibility of Biotechnological Inventions in the United States, Europe, and Japan: How Much Patent Policy is Public Policy? George Washington International Law Review 2002 34 223 246
  19. Conley 2009 Conley J. M Gene Patents and the Product of Nature Doctrine Chicago-Kent Law Review 2009 84 109 132
  20. Conley and Makowski 2003 Conley J. M Makowski R Back to the Future: Rethinking the Product of Nature Doctrine as a Barrier to Biotechnology Patents (Part II) Journal of the Patent & Trademark Office Society 2003 85 371 385
  21. Contreras 2010 Contreras J. L Data Sharing, Latency Variables and the Science Commons Berkeley Technology Law Journal 2010 25 1601 1672
  22. Crescenzi 2012 Crescenzi A Bin R Access to Genetic Resources in the Practices of States Biotech Innovations and Fundamental Rights 2012 Milano Springer 345 353
  23. Crespi 2003 Crespi R. S Patenting and Ethics – A Dubious Connection Journal of the Patent & Trademark Office Society 2003 85 31 47
  24. Crespi 2005 Crespi R. S Ethico-Legal Issues in Biomedicine Patenting: A Patent Professional Viewpoint Science and Engineering Ethics 2005 11 117 136
  25. Crichton 2007 Crichton M Patenting Life N.Y. Times 2007 2 13 A23
  26. David and Foray 1995 David P Foray D Accessing and Expanding the Science and Technology Knowledge Base OECD Science Technology Industry Review 1995 16 13 68
  27. Dedeurwaerdere 2005 Dedeurwaerdere T From Bioprospecting to Reflexive governance Ecological Economics 2005 53 473 491
  28. Deibel 2009 Deibel E Common Genomes: An Open Source in Biology & Critical Theory Beyond the Patent 2009 Amsterdam Vrije Universiteit
  29. Doll 1998 Doll J. J The Patenting of DNA Science 1998 280 689 690
  30. Eisemberg 1990 Eisemberg R Patenting the Human Genome Emory Law Journal 1990 39 721 745
  31. Eisemberg 2006 Eisemberg R. S Ginzburg J. C Dreyfuss R. C The Story of Diamond v. Chakrabarty: Technological Change and the Subject Matter Boundaries of the Patent System Intellectual Property Stories 2006 New York Foundation Press 327 357
  32. European Commission 2006 European Commission Communication from the Commission to the Council and the European Parliament: Delivering on the modernisation agenda for universities: education, research and innovation. Brussels, 208 final of 10.5.2006 2006
  33. European Patent Office 2007 European Patent Office Scenarios For The Future – How Might IP Regimes Evolve by 2025? What Global Legitimacy Might Such Regimes Have? 2007 Munich European Patent Organisation
  34. Finegold et al. 2005 Finegold D. L Bensimon C. M Daar A. S Eaton M. L Beatrice Godard B Knoppers B. M Mackie J Singer P. A Bioindustry Ethics 2005 Boston, MA Elsevier Academic Press
  35. Frison et al. 2010 Frison C Dedeurwaerdere T Halewood M Intellectual Property and Facilitated Access to Genetic Resources under the International Treaty on Plant Genetic Resources for Food and Agriculture European Intellectual Property Review 2010 32 1 8
  36. Garforth 2008 Garforth K Gibson J Life as Chemistry or Life as Biology? An Ethic of Patents on Genetically Modified Organisms” Patenting Lives: Life Patents, Culture and Development 2008 Aldershot Ashgate 27 52
  37. Geetter 2011 Geetter J. S Another Man’s Treasure: The Promise and Pitfalls of Leveraging Existing Biomedical Assets for Future Use Journal of Health & Life Scieces Law 2011 4 1 104
  38. Ghosh 2012 Ghosh S Identity, Invention, and the Culture of Personalized Medicine Patenting 2012 Cambridge Cambridge University Press
  39. Gibson 2008 Gibson J Gibson J Patent Publics, Patent Cultures Patenting Lives: Life Patents, Culture and Development 2008 Aldershot Ashgate 1 6
  40. Gitter 2001 Gitter D. M International Conflicts Over Patenting Human DNA Sequences in the United States and the European Union: An Argument for Compulsory Licensing and a Fair-Use Exemption N.Y.U. Law Review 2001 76 1623 1691
  41. Gold and Carbone 2010 Gold E. R Carbone J Myriad Genetics: In the Eye of the Policy Storm Genetics in Medicine 2010 12 S39 S70
  42. Guellec and van Pottelsberghe de la Potterie 2007 Guellec D van Pottelsberghe de la Potterie B The Economics of the European Patent System: IP Policy for Innovation and Competition 2007 Oxford Oxford University Press
  43. Hamelink 2003 Hamelink C. J Girard B Siochrú S. Ó Human Rights for the Information Society Communicating in the Information Society 2003 Geneve United Nations Research Institute for Social Development 121 163
  44. Hanson 2002 Hanson M. J Magnus D Patenting Genes and Life: Improper Commodification? Who Owns Life? 2002 New York Prometheus Books 161 174
  45. Hardin 1968 Hardin G The Tragedy of the Commons Science 1968 162 1243 1248
  46. Heller 2008 Heller M The Gridlock Economy: How Too Much Ownership Wrecks Markets, Stops Innovation, and Costs Lives 2008 New York, NY Basic Books
  47. Heller and Eisenberg 1998 Heller M. A Eisenberg R Can Patents Deter Innovation? The Anticommons in Biomedical Research Science 1998 280 698 701
  48. Hess and Ostrom 2006a Hess C Ostrom E Understanding Knowledge as a Commons: From Theory to Practice 2006a Cambridge MIT Press
  49. Hess and Ostrom 2006b Hess C Ostrom E A Framework for Analysing the Microbiological Commons International Social Science Journal 2006b 58 335 350
  50. Holman 2013 Holman C. M In Myriad the Supreme Court Has, Once Again, Increased the Uncertainty of U.S. Patent Law Biotechnology Law Report 2013 32 1 5
  51. Hovenkamp et al. 2006 Hovenkamp H. J Janis M. D Lemley M. A Unilateral Refusals to License in the US Journal of Competition Law and Economics 2006 2 1 42
  52. Howlett and Christie 2003 Howlett M. J Christie A. F An Analysis of the Approach of the European, Japanese and United States Patent Offices to Patenting Partial DNA Sequences (ESTs) International Review of Industrial Property and Copyright 2003 34 581 602
  53. Joint Policy Statement 1998 Joint Policy Statement Trilateral Co-operation of the US, European, and Japanese Patent Offices US, Japan and European Patent Offices Biotechnology Law Review 1998 7 159 193
  54. Katz 1997 Katz E Nature as Subject: Human Obligation and Natural Community 1997 Lanham, MD Rowman and Littlefield
  55. Kevles and Berkowitz 2001 Kevles D. J Berkowitz A The Gene Patenting Controversy: A Convergence of Law, Economic Interests, and Ethics Brooklyn Law Review 2001 67 233 248
  56. Koepsell 2009 Koepsell D Who Owns You? The Corporate Gold-Rush To Patent Your Genes 2009 Malden, Ma Wiley-Blackwell
  57. Larrimore Ouellette 2010 Larrimore Ouellette L Access to Bio-Knowledge: From Gene Patents to Biomedical Materials Stanford Technology Law Review 2010 2010 1 27
  58. Liivak 2007 Liivak O Maintaining Competition in Copying: Narrowing the Scope of Gene Patents U.C. Davis Law Review 2007 41 177 238
  59. Litman 1990 Litman J The Public Domain Emory Law Journal 1990 39 965 1023
  60. Macchia 2012 Macchia G Bin R Patentability Requirements of Biotech Inventyions at the European Patent Office: Ethical Issues Biotech Innovations and Fundamental Rights 2012 Milano Springer 37 43
  61. Madison et al. 2010 Madison M. J Frischmann B. M Strandburg K. J Constructing Commons in the Cultural Envinronment Cornell Law Review 2010 95 657 709
  62. Mattix 1999 Mattix C The Debate over Bioprospecting on the Public Lands National Resources and Environment 1999 13 528 532
  63. Michaels 1999 Michaels D Bioprospecting Agreements: Forging a Comprehensive Strategy for Managing Genetic Resources on Public Lands Environmental Law And Policy Journal 1999 22 3 70
  64. Miki et al. 1994 Miki Y Swensen J Shattuck-Eidens D Futreal P. A Harshman K Tavtigian S Liu Q Cochran C Bennett L. M Ding W A Strong Candidate for the Breast and Ovarian Cancer Susceptibility Gene BRCA1 Science 1994 266 66 71
  65. Mills 2010 Mills O Biotechnological Inventions. Moral Restraints and Patent Law 2010 2nd ed Farnham Ashgate
  66. Moran et al. 2001 Moran K King S. R Carlson T. J Biodiversity Prospecting: Lessons and Prospects Annual Review of Anthropology 2001 30 505 526
  67. Murray and Stern 2007 Murray F Stern S Do Formal Intellectual Property Rights Hinder the Free Flow of Scientific Knowledge? An Empirical Test of the Anti-Commons Hypothesis The Journal of Economic behavior and Organization 2007 63 648 687
  68. National Research Council 2011 National Research Council – Committee on a Framework for Development a New Taxonomy of Disease Toward Precision Medicine: Building a Knowledge Network for Biomedical Research and a New Taxonomy of Disease 2011 Washington, DC The National Academies Press
  69. Ostrom 1990 Ostrom E Governing the Commons: The Evolution of Institutions for Collective Action 1990 Cambridge Cambridge University Press
  70. Paradise 2005 Paradise J. K Lessons from the European Union: The Need for a Post-Grant Mechanism for Third-Party Challenge to U.S. Patents Minnesota Journal of Law, Science & Technology 2005 7 315 325
  71. Personalized Medicine Coalition Personalized Medicine Coalition Personalized Medicine 101. Available online at: http://www.personalizedmedicinecoalition.org/about/about-personalized-medicine/personalized-medicine-101.
  72. Qualset and Webster 1998 Qualset C. O Webster R. K Biotechnology: New benefits, New Questions California Agriculture 1998 52 2 2
  73. Rai 1999 Rai A. K Regulating Scientific Research: Intellectual Property Rights and the Norms of Science Northwestern University Law Review 1999 94 77 152
  74. Rai 2007 Rai A. K Knowledge Commons: The Case of Biopharmaceutical Industry First Monday 2007 6 4 Available at: http://firstmonday.org/issue12_6/rai/index.html.
  75. Rai and Eisenberg 2003 Rai A. K Eisenberg R. S Bayh-Dole Reform and the Progress of Biomedicine Law & Contemporary Problems 2003 66 289 314
  76. Reese and Opeskin 2006 Reese A Opeskin B Freckelton I Petersen K Current Issues in Gene Patenting Disputes and Dilemmas in Health Law 2006 Annandale, N.S.W. Federation Press 277 295
  77. Reichman and Dreyfuss 2007 Reichman J. H Dreyfuss R. C Harmonization Without Consensus: Critical Reflections on Drafting a Substantive Patent Law Treaty Duke Law Journal 2007 57 85 130
  78. Reinisch 2010 Reinisch A Reinisch A Decisions of the European Patent Organization Before National Courts Challenging Acts of International Organizations Before National Courts 2010 Oxford Oxford University Press 137 156
  79. Resnik 2004 Resnik D. B Owning the Genome: A Moral Analysis of DNA Patenting 2004 Albany SUNY Press
  80. Resta 2011 Resta G Resta G Nuovi Beni Immateriali e Numerus Clausus dei Diritti Esclusivi Diritti Esclusivi e Nuovi Beni Immateriali 2011 Torino Utet 3 72
  81. Restaino et al. 2003 Restaino L. G Halpern S. E Tang E. L Patenting DNA-Related Inventions in the European Union, United States and Japan: A Trilateral Approach or a Study in Contrast? UCLA Journal of Law & Technology 2003 7 2 25
  82. Robinson and Medlock 2005 Robinson D Medlock N Diamond v. Chakrabarty: A Retrospective on 25 Years of Biotech Patents Intellectual Property & Technology Law Journal 2005 17 12 15
  83. Saladino 2011 Saladino T Seeing the Forest Through the Trees: Gene Patents & the Reality of the Commons Berkeley Technology Law Journal 2011 26 301 328
  84. Samuelson 2003 Samuelson P Mapping the Digital Public Domain: Threats and Opportunities Law & Contemporary Problems 2003 66 147 171
  85. Samuelson 2006 Samuelson P Enriching Discourse on Public Domains Duke Law Journal 2006 55 783 834
  86. Sarnoff 2011 Sarnoff J. D Patent Eligible Medical and Biotechnology Inventions After Bilski, Prometheus, and Myriad Texas Intellectual Property Law Journal 2011 19 393 418
  87. Sarr and Swanson 2012 Sarr M Swanson T Brousseau E Governance of the Research and Development Sector for Biotechnology: Intellectual Property Rights and Bioprospecting Reflexive Governance for Global Public Goods 2012 Cambridge, MA MIT Press 105 122
  88. Sedjo 1992 Sedjo R. A Property Rights, Genetic Resources, and Biotechnological Change Journal of Law and Economics 1992 35 199 213
  89. Shiva 1997 Shiva V Biopiracy: The Plunder of Nature and Knowledge 1997 Cambridge, Ma South End Press
  90. Spinello and Bottis 2009 Spinello R. A Bottis M A Defense of Intellectual Property Rights 2009 Cheltenham Edward Elgar
  91. U.S. Dep’t of Health & Human Services 2007 U.S. Dep’t of Health & Human Services Personalized Health Care: Opportunities, Pathways, Resources. Available online at: www.hhs.gov/myhealthcare/news/phc-report.pdf 2007
  92. U.S. Dep’t of Health & Human Services 2008 U.S. Dep’t of Health & Human Services Personalized Health Care Pioneers, Partnerships, Progress. Available online at; www.hhs.gov/myhealthcare/news/phc_2008_report.pdf 2008
  93. U.S. Department of Justice and Federal Trade Commission 2011 U.S. Department of Justice and Federal Trade Commission The Evolving IP Marketplace: Aligning Patent Notice and Remedies With Competition 2011 Washington DC Federal Trade Commission
  94. Van Overwalle 2010a Van Overwalle G Grosheide W Human Rights’ Limitations in Patent Law Intellectual Property And Human Rights. A Paradox 2010a Cheltenham Edward Elgar Publishing 236 271
  95. Van Overwalle 2010b Van Overwalle G Turning Patent Swords into Shares Science 2010b 330 1630 1631
  96. Van Overwalle et al. 2006 Van Overwalle G Van Zimmeren E Verbeure B Matthijs G Models for Facilitating Access to Patents on Genetic Inventions Nature Review Genetics 2006 7 143 154
  97. von der Ropp and Taubman 2006 von der Ropp A Taubman T Bioethics and Patent Law: The Case of Myriad WIPO Magazine 2006 4 8 9
  98. Walsh et al. 2003 Walsh J. P Arora A Cohen W. M Working Through the Patent Problem Science 2003 299 1021
  99. Willard and Ginsburg 2009 Willard H. F Ginsburg G. S Essentials of Genomic and Personalized Medicine 2009 Boston Academic Press
  100. Wood 2000 Wood M Are National Park Resources for Sale? Public Land & Resources Law Review 2000 21 201 222
  101. Wright 2010 Wright T Patent Trends in the U.S. Supreme Court.Available at: http://brandlaw.org/2010/01/patent-trends-in-the-u-s-supreme-court/ (last visited Dec. 22, 2012) 2010
DOI: https://doi.org/10.18352/ijc.399 | Journal eISSN: 1875-0281
Language: English
Published on: Aug 29, 2013
Published by: Igitur Publishing
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year

© 2013 Nicola Lucchi, published by Igitur Publishing
This work is licensed under the Creative Commons Attribution 4.0 License.